Odd Erik Johansen, MD, PhD, MBA

Addressing Nutritional Challenges for People with Obesity on GLP-1 Based Therapies

Learn about physiologic and clinical characteristics of weight reduction obtained with glucagon-like peptide-1 (GLP-1) based therapies and nutritional challenges that people with obesity face.

2/2/2024 By Ian Neeland, MD and Odd Erik Johansen, MD, PhD, MBA